101990-73-2

Basic information

• Product Name: Pyridine, 2-chloro-4-(chloromethyl)- (9CI)
• Synonyms: Pyridine, 2-chloro-4-(chloromethyl)- (9CI);2-Chloro-4-(chloroMethyl)pyridine, 97+%;Pyridine, 2-chloro-4-(chloromethyl)-
• CAS NO: 101990-73-2
• Molecular Formula: C₆H₅Cl₂N
• Molecular Weight: 162.0166
• EINECS: 1312995-182-4
• Product Categories: PYRIDINE
• Mol File: 101990-73-2.mol
• Article Data: 17

Chemical Properties

• Melting Point: 123-125℃
• Boiling Point: 234oC at 760 mmHg
• Flash Point: 117.9oC
• Appearance: /
• Density: 1.324
• Vapor Pressure: 0.0825mmHg at 25°C
• Refractive Index: 1.55
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 0.13±0.10(Predicted)
• CAS DataBase Reference: Pyridine, 2-chloro-4-(chloromethyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Pyridine, 2-chloro-4-(chloromethyl)- (9CI)(101990-73-2)
• EPA Substance Registry System: Pyridine, 2-chloro-4-(chloromethyl)- (9CI)(101990-73-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 101990-73-2(Hazardous Substances Data)

Usage

General Description

Pyridine, 2-chloro-4-(chloromethyl)- (9CI) is an organic compound with the molecular formula C6H8Cl2N. It is a derivative of pyridine with two chlorine atoms and a chloromethyl group attached to the second and fourth positions of the pyridine ring, respectively. Pyridine, 2-chloro-4-(chloromethyl)- (9CI) is used in various industrial processes, including as a building block in the synthesis of pharmaceuticals and agrochemicals. It is also utilized in the production of rubber chemicals and dyes. Additionally, it can act as a reagent in organic chemical reactions, serving as a precursor for the modification of other compounds. However, it is important to handle this chemical with caution, as it is flammable and may pose health hazards if not handled properly.

InChI:InChI=1/C6H5Cl2N/c7-2-5-1-6(8)4-9-3-5/h1,3-4H,2H2

Upstream product

• 3678-62-4 2-chloro-4-picoline 
• 100704-10-7 (2-chloropyridin-4-yl)methanol 
• 65287-34-5 2-chloropyridine-4-carbonyl chloride 

Downstream Products

• 945257-67-0 1-[(2-chloropyridin-4-yl)methyl]-5,5-dimethyl-3-{4-[(trifluoromethyl)thio]phenyl}imidazolidine-2,4-dione 
• 937236-73-2 ethyl 2-(2-chloropyridin-4-yl)acetate 
• 945104-02-9 3-(4-tert-butyl-phenyl)-1-(2-chloro-pyridin-4-ylmethyl)-5,5-dimethyl-imidazolidine-2,4-dione 
• 945103-89-9 3-[3-amino-4-(trifluoromethoxy)phenyl]-1-[(2-chloropyridin-4-yl)methyl]-5,5-dimethylimidazolidine-2,4-dione 
• 945103-94-6 3-{3-amino-4-[(trifluoro-methyl)thio]phenyl}-1-[(2-chloropyridin-4-yl)methyl]-5,5-dimethylimidazolidine-2,4-dione 
• 945104-50-7 2-{4-[3-(2-chloropyridin-4-ylmethyl)-4,4-dimethyl-2,5-dioxo-imidazolidin-1-yl]-phenyl}-2-methylpropionic acid methyl ester 
• 945257-71-6 1-[(2-chloropyridin-4-yl)methyl]-5,5-dimethyl-3-{4-[(trifluoromethyl)sulfonyl]phenyl}imidazolidine-2,4-dione 
• 1204701-61-0 2-chloro-4-(pyrrolidin-1-ylmethyl)pyridine 
• 1204701-62-1 1-(2-chloropyridin-4-ylmethyl)-4-benzyloxyacetyl-piperazine 
• 1225380-68-6 2-Chloro-4-[(5-methyl-3-{3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl}-1H-pyrazol-1-yl)-methyl]pyridine 
• 1418296-59-9 2-chloro-4-[(3-{(Z)-1-fluoro-2-[4-(trimethylsilyl)phenyl]vinyl}-5-methyl-1H-pyrazol-1-yl)-methyl]pyridine 
• 1418296-61-3 1-{4-[(3-{(Z)-1-fluoro-2-[4-(trimethylsilyl)phenyl]vinyl}-5-methyl-1H-pyrazol-1-yl)methyl]-pyridin-2-yl}piperazine 
• 1418296-67-9 1-cyclopropyl-4-{4-[(3-{(Z)-1-fluoro-2-[4-(trimethylsilyl)phenyl]vinyl}-5-methyl-1H-pyrazol-1-yl)methyl]pyridin-2-yl}piperazine 
• 1227159-13-8 1-(4-{[5-methyl-3-(3-{4-[1-(trifluoromethyl)cyclopropyl]phenyl}-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl]methyl}pyridin-2-yl)piperazine 

Relevant articles and documents

SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER

Disclosed are compounds of Formula (I) or a salt thereof, wherein Ring A is a carbon-linked ring; and Ring A, R1, and n are defined herein. Also disclosed are methods of using such compounds to inhibit Helios protein, and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.

HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS

The present application relates to novel aryl compounds with heterocyclic substituents, processes for their preparation, their use for treatment and/or prevention of diseases and their use for the preparation of medicaments for treatment and/or prevention

HETEROAROMATIC COMPOUNDS FOR USE AS HIF INHIBITORS

The present application relates to novel substituted aryl compounds, processes for their preparation, their use for treatment and/or prevention of diseases and their use for the preparation of medicaments for treatment and/or prevention of diseases, in particular for treatment and/or prevention of hyperproliferative and angiogenic diseases and those diseases which arise from metabolic adaptation to hypoxic states. Such treatments can be carried out as monotherapy or also in combination with other medicaments or further therapeutic measures.